322
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Screening and Drug Resistance Analysis of Non-Tuberculous Mycobacteria in Patients with Suspected Pulmonary Tuberculosis on the Hainan Island, China

, , , , , & ORCID Icon show all
Pages 463-476 | Received 11 Nov 2022, Accepted 16 Jan 2023, Published online: 25 Jan 2023

References

  • Stout JE, Koh WJ, Yew WW. Update on pulmonary disease due to non-tuberculous mycobacteria. Int J Infect Dis. 2016;45:123–134. doi:10.1016/j.ijid.2016.03.006
  • Good RC, Snider DE. Isolation of nontuberculous mycobacteria in the United States, 1980. J Infect Dis. 1982;146(6):829–833. doi:10.1093/infdis/146.6.829
  • Medical Section of the American Lung Association. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Am J Respir Crit Care Med. 1997;156(2 Pt 2):S1–25. doi:10.1164/ajrccm.156.2.atsstatement
  • Latshang TD, Lo Cascio CM, Russi EW. Atypische Mykobakteriose der Lunge [Nontuberculous mycobacterial infections of the lung]. Ther Umsch. 2011;68(7):402–406. German. doi:10.1024/0040-5930/a000184
  • Li G, Pang H, Guo Q, et al. Antimicrobial susceptibility and MIC distribution of 41 drugs against clinical isolates from China and reference strains of nontuberculous mycobacteria. Int J Antimicrob Agents. 2017;49(3):364–374. doi:10.1016/j.ijantimicag.2016.10.024
  • Sun Q, Yan J, Liao X, et al. Trends and species diversity of non-tuberculous mycobacteria isolated from respiratory samples in Northern China, 2014–2021. Front Public Health. 2022;10:923968. doi:10.3389/fpubh.2022.923968
  • Wang L, Zhang H, Ruan Y, et al. Tuberculosis prevalence in China, 1990–2010; a longitudinal analysis of national survey data. Lancet. 2014;383(9934):2057–2064. doi:10.1016/S0140-6736(13)62639-2
  • Lopez-Roa P, Aznar E, Cacho J, et al. Epidemiology of Non-Tuberculous Mycobacteria isolated from clinical specimens in Madrid, Spain, from 2013 to 2017. Eur J Clin Microbiol Infect Dis. 2020;39(6):1089–1094. doi:10.1007/s10096-020-03826-7
  • Zhang H, Luo M, Zhang K, et al. Species identification and antimicrobial susceptibility testing of non-tuberculous mycobacteria isolated in Chongqing, Southwest China. Epidemiol Infect. 2020;149:e7. doi:10.1017/S0950268820003088
  • Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416. doi:10.1164/rccm.200604-571ST
  • Mougari F, Loiseau J, Veziris N, et al. Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria. J Antimicrob Chemother. 2017;72(6):1669–1677. doi:10.1093/jac/dkx021
  • Liu CF, Song YM, He WC, et al. Nontuberculous mycobacteria in China: incidence and antimicrobial resistance spectrum from a nationwide survey. Infect Dis Poverty. 2021;10(1):59. doi:10.1186/s40249-021-00844-1
  • Shao Y, Chen C, Song H, et al. The epidemiology and geographic distribution of nontuberculous mycobacteria clinical isolates from sputum samples in the eastern region of China. PLoS Negl Trop Dis. 2015;9(3):e0003623. doi:10.1371/journal.pntd.0003623
  • Lin M, Zhong Y, Chen Z, et al. High incidence of drug-resistant Mycobacterium tuberculosis in Hainan Island, China. Trop Med Int Health. 2019;24(9):1098–1103. doi:10.1111/tmi.13285
  • People’s Republic of China and Family Planning Commission. Diagnosis of Tuberculosis. Beijing: People’s Republic of China and Family Planning Commission; 2017.
  • Liu H, Lian L, Jiang Y, et al. Identification of species of nontuberculous mycobacteria clinical isolates from 8 provinces of China. Biomed Res Int. 2016;2016:2153910. doi:10.1155/2016/2153910
  • McNabb A, Eisler D, Adie K, et al. Assessment of partial sequencing of the 65-kilodalton heat shock protein gene (hsp65) for routine identification of Mycobacterium species isolated from clinical sources. J Clin Microbiol. 2004;42(7):3000–3011. doi:10.1128/JCM.42.7.3000-3011.2004
  • Clinical and Laboratory Standards Institute. Susceptibility testing of mycobacteria, Nocardia spp., and other aerobic actinomycetes. 3rd ed. In: CLSI Standard Document M24. Wayne, PA: Clinical and Laboratory Standards Institute; 2018.
  • Karamat A, Ambreen A, Ishtiaq A, Tahseen S, Rahman MA, Mustafa T. Isolation of non-tuberculous mycobacteria among tuberculosis patients, a study from a tertiary care hospital in Lahore, Pakistan. BMC Infect Dis. 2021;21(1):381. doi:10.1186/s12879-021-06086-8
  • Wani SR, Wattal C, Raveendran R. Epidemiology and risk factors associated with NTM pulmonary and extrapulmonary infections in a high tuberculosis endemic Region. Indian J Med Microbiol. 2020;38(2):169–175. doi:10.4103/ijmm.IJMM_20_274
  • Thangavelu K, Krishnakumariamma K, Pallam G, et al. Prevalence and speciation of non-tuberculous mycobacteria among pulmonary and extrapulmonary tuberculosis suspects in South India. J Infect Public Health. 2021;14(3):320–323. doi:10.1016/j.jiph.2020.12.027
  • Huang JJ, Li YX, Zhao Y, et al. Prevalence of nontuberculous mycobacteria in a tertiary hospital in Beijing, China, January 2013 to December 2018. BMC Microbiol. 2020;20(1):158. doi:10.1186/s12866-020-01840-5
  • Furuuchi K, Morimoto K, Yoshiyama T, et al. Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan. Respir Med. 2019;152:74–80. doi:10.1016/j.rmed.2019.05.001
  • Chalermskulrat W, Gilbey JG, Donohue JF. Nontuberculous mycobacteria in women, young and old. Clin Chest Med. 2002;23(3):675–686. doi:10.1016/S0272-5231(02)00010-2
  • Moon P, Guillaumin E, Chan ED. Non-tuberculous mycobacterial lung disease due to multiple “minor” risk factors: an illustrative case and a review of these “lesser elements”. J Thorac Dis. 2020;12(9):4960–4972. doi:10.21037/jtd-20-986
  • Bastian S, Veziris N, Roux AL, et al. Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing. Antimicrob Agents Chemother. 2011;55(2):775–781. doi:10.1128/AAC.00861-10
  • Richard M, Gutierrez AV, Kremer L. Dissecting erm (41)-mediated macrolide-inducible resistance in mycobacterium abscessus. Antimicrob Agents Chemother. 2020;64(2). doi:10.1128/AAC.01879-19
  • Wallace RJ, Dukart G, Brown-Elliott BA, Griffith DE, Scerpella EG, Marshall B. Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections. J Antimicrob Chemother. 2014;69(7):1945–1953. doi:10.1093/jac/dku062
  • Hatakeyama S, Ohama Y, Okazaki M, Nukui Y, Moriya K. Antimicrobial susceptibility testing of rapidly growing mycobacteria isolated in Japan. BMC Infect Dis. 2017;17(1):197. doi:10.1186/s12879-017-2298-8
  • Zhang ZX, Cherng BPZ, Sng LH, Tan YE. Clinical and microbiological characteristics of non-tuberculous mycobacteria diseases in Singapore with a focus on pulmonary disease, 2012–2016. BMC Infect Dis. 2019;19(1):436. doi:10.1186/s12879-019-3909-3
  • Lee JS, Lee JH, Yoon SH, et al. Implication of species change of nontuberculous mycobacteria during or after treatment. BMC Pulm Med. 2017;17(1):213. doi:10.1186/s12890-017-0539-7
  • Huang M, Tan Y, Zhang X, et al. Effect of mixed infections with mycobacterium tuberculosis and nontuberculous mycobacteria on diagnosis of multidrug-resistant tuberculosis: a retrospective multicentre study in China. Infect Drug Resist. 2022;15:157–166. doi:10.2147/IDR.S341817
  • Kendall BA, Varley CD, Hedberg K, Cassidy PM, Winthrop KL. Isolation of non-tuberculous mycobacteria from the sputum of patients with active tuberculosis. Int J Tuberculosis Lung Dis. 2010;14(5):654–656.
  • Andrejak C, Nielsen R, Thomsen VO, Duhaut P, Sorensen HT, Thomsen RW. Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis. Thorax. 2013;68(3):256–262. doi:10.1136/thoraxjnl-2012-201772
  • Simons S, van Ingen J, Hsueh PR, et al. Nontuberculous mycobacteria in respiratory tract infections, Eastern Asia. Emerg Infect Dis. 2011;17(3):343–349. doi:10.3201/eid170310060
  • Hu C, Huang L, Cai M, Wang W, Shi X, Chen W. Characterization of non-tuberculous mycobacterial pulmonary disease in Nanjing district of China. BMC Infect Dis. 2019;19(1):764. doi:10.1186/s12879-019-4412-6
  • Meghji J, Lesosky M, Joekes E, et al. Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study. Thorax. 2020;75(3):269–278. doi:10.1136/thoraxjnl-2019-213808
  • Johansen MD, Herrmann JL, Kremer L. Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus. Nat Rev Microbiol. 2020;18(7):392–407. doi:10.1038/s41579-020-0331-1
  • Nour-Neamatollahie A, Ebrahimzadeh N, Siadat SD, et al. Distribution of non-tuberculosis mycobacteria strains from suspected tuberculosis patients by heat shock protein 65 PCR-RFLP. Saudi J Biol Sci. 2017;24(6):1380–1386. doi:10.1016/j.sjbs.2016.02.001
  • Liang Q, Shang Y, Huo F, et al. Assessment of current diagnostic algorithm for detection of mixed infection with Mycobacterium tuberculosis and nontuberculous mycobacteria. J Infect Public Health. 2020;13(12):1967–1971. doi:10.1016/j.jiph.2020.03.017
  • Kim SH, Shin JH. Identification of nontuberculous mycobacteria using multilocous sequence analysis of 16S rRNA, hsp65, and rpoB. J Clin Lab Anal. 2018;32(1). doi:10.1002/jcla.22184
  • Xu Y, Liang B, Du C, et al. Rapid identification of clinically relevant mycobacterium species by multicolor melting curve analysis. J Clin Microbiol. 2019;57(1). doi:10.1128/JCM.01096-18